EAM
Exome Asset Management Portfolio holdings
AUM
$110M
This Quarter Return
+9.77%
1 Year Return
+24.83%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$133M
AUM Growth
+$133M
(-10%)
Cap. Flow
-$18.2M
Cap. Flow
% of AUM
-13.66%
Top 10 Holdings %
Top 10 Hldgs %
37.04%
Holding
83
New
23
Increased
11
Reduced
18
Closed
24
Top Buys
| 1 |
Humana
HUM
|
$4.58M |
| 2 |
Syndax Pharmaceuticals
SNDX
|
$4.22M |
| 3 |
Arvinas
ARVN
|
$4.19M |
| 4 |
Boston Scientific
BSX
|
$3.62M |
| 5 |
Soleno Therapeutics
SLNO
|
$3.47M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$6.55M |
| 2 |
TG Therapeutics
TGTX
|
$4.86M |
| 3 |
Align Technology
ALGN
|
$4.76M |
| 4 |
Cigna
CI
|
$4.23M |
| 5 |
BioNTech
BNTX
|
$4.1M |
Sector Composition
| 1 | Healthcare | 98.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
BioCryst Pharmaceuticals
BCRX
$1.74B
| – | – |
-196,500
| Closed | -$1.49M |
|
77
Biogen
BIIB
$20.5B
| – | – |
-13,317
| Closed | -$2.57M |
|
|
78
BioNTech
BNTX
$24.1B
| – | – |
-34,552
| Closed | -$4.1M |
|
|
79
Cigna
CI
$80.2B
| – | – |
-12,200
| Closed | -$4.23M |
|
80
Glaukos
GKOS
$5.42B
| – | – |
-25,857
| Closed | -$3.37M |
|
81
Insmed
INSM
$30.3B
| – | – |
-33,600
| Closed | -$2.45M |
|
82
Kura Oncology
KURA
$732M
| – | – |
-90,305
| Closed | -$1.76M |
|